NovoNexile
Developer of a flowable, instant-setting hydrogel graft platform for regenerative medicine. The company focuses on biomaterials engineered for guided bone and tissue regeneration and on integrating those materials with digitally guided and minimally invasive clinical workflows. Development emphasis includes formulation adaptability, scalability, and collaborative development with specialised partners.
Industries
Nr. of Employees
small (1-50)
NovoNexile
Products
Flowable instant-setting grafts and membranes for guided bone and tissue regeneration
Flowable hydrogel grafts and membranes that set on application to conform to defect shapes, designed for use in guided bone and tissue regeneration, with described dental and periodontal use cases.
Flowable instant-setting grafts and membranes for guided bone and tissue regeneration
Flowable hydrogel grafts and membranes that set on application to conform to defect shapes, designed for use in guided bone and tissue regeneration, with described dental and periodontal use cases.
Services
Organised early-access and hands-on evaluation opportunities for clinicians to trial flowable graft and membrane materials.
Organised early-access and hands-on evaluation opportunities for clinicians to trial flowable graft and membrane materials.
Expertise Areas
- Regenerative biomaterials
- Guided bone and tissue regeneration
- Dental and periodontal regenerative solutions
- Formulation development and platform adaptability
Key Technologies
- Flowable hydrogel biomaterials
- Instant-setting scaffold materials
- Membrane and graft formulations for bone regeneration
- Formulation combinatorics for indication adaptation
News & Updates
Selected as one of the top three finalists from 100 Swiss start-ups in the Swiss Innovation Challenge 2025; presented business and implementation plans to a multi-stage jury.
Selected as one of the top three finalists from 100 Swiss start-ups in the Swiss Innovation Challenge 2025; presented business and implementation plans to a multi-stage jury.